HCG Oncology Hospitals LLP
About HCG Oncology Hospitals LLP
Data last updated:
HCG Oncology Hospitals LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 31 May 2013 and has been in existence for over 13 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAB-5593.
The LLP has a total obligation of contribution of ₹143.11 Cr. It is led by designated partners Ramesh S Bilimagga and Srinivasa Venkatavaradhan Raghavan.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹63 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net loss of ₹10.54 Cr (net margin -16.7%) and EBITDA of -₹6.98 Cr (EBITDA margin -11.1%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 47% over five years.
The LLP has about 165 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹47.5 Cr on record.
Company details
Contact details
HCG Oncology Hospitals LLP's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressHcg Tower No.8 P. Kalinga Rao Road, Sampangi Rama Nagar, Bangalore, Karnataka, India – 560027
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of HCG Oncology Hospitals LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of HCG Oncology Hospitals LLP
FY 2025 filings availableHCG Oncology Hospitals LLP reported revenue of ₹63 Cr (up 12% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 47% over five years, including 12% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | -₹10.54 Cr | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -16.7% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of HCG Oncology Hospitals LLP, buy the company report.
Designated partners of HCG Oncology Hospitals LLP
HCG Oncology Hospitals has 2 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh S Bilimagga | Designated Partner | 01 Aug 2018 | 8 Years 3 Months | Current |
| Srinivasa Venkatavaradhan Raghavan Also directs: HCG Medi-Surge Hospitals Private Limited, HCG Nchri Oncology LLP, HCG Manavata Oncology LLP and 2 more | Designated Partner | 24 Aug 2019 | 7 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Apr 2016 | 100038218 | Yes Bank Limited | ₹47.5 Cr | Open |
To see the full charge records of HCG Oncology Hospitals LLP, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving HCG Oncology Hospitals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
HCG Oncology Hospitals LLP was last rated by Icra on 22 Dec 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 22 Dec 2022 |
To see the full credit ratings and regulatory alerts of HCG Oncology Hospitals LLP, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HCG Oncology Hospitals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
HCG Oncology Hospitals LLP has a workforce of 165 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
GST
No GST registration is on our record for HCG Oncology Hospitals LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
HCG Oncology Hospitals LLP has 6 designated partner changes on record since 2016: 2 appointments and 4 cessations. The latest: Srinivasa Venkatavaradhan Raghavan was appointed as Designated Partner on 24 Aug 2019.
Frequently asked questions
HCG Oncology Hospitals is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 31 May 2013 (13+ years old) and is registered under LLPIN AAB-5593.
HCG Oncology Hospitals has 2 current designated partners:
- Ramesh S Bilimagga - Designated Partner
- Srinivasa Venkatavaradhan Raghavan - Designated Partner
The latest financial statements of HCG Oncology Hospitals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of HCG Oncology Hospitals is AAB-5593. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
HCG Oncology Hospitals was incorporated on 31 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
Srinivasa Venkatavaradhan Raghavan was appointed as Designated Partner on 24 Aug 2019. Dinesh Madhavan ceased to be Designated Partner on 23 Aug 2019. Ramesh S Bilimagga was appointed as Designated Partner on 01 Aug 2018. HCG Oncology Hospitals has 6 designated partner changes on record in total.
The registered office of HCG Oncology Hospitals is at Hcg Tower No.8 P. Kalinga Rao Road, Sampangi Rama Nagar, Bangalore, Karnataka, India – 560027.
HCG Oncology Hospitals operates in the healthcare industry, in the oncology clinics and cancer treatment segment.
HCG Oncology Hospitals has open charges of ₹47.5 Cr and no satisfied charges on record as per latest MCA filings.
HCG Oncology Hospitals can be reached at its registered office: Hcg Tower No.8 P. Kalinga Rao Road, Sampangi Rama Nagar, Bangalore, Karnataka, India – 560027.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
